IMPRIMIS PHARMACEUTICALS INC - COM NEW (IMMY)

Historical Holders from Q1 2014 to Q2 2020

Type / Class
Equity / COM NEW
Symbol
IMMY
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of IMPRIMIS PHARMACEUTICALS INC - COM NEW (IMMY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2020 Q2 0 $0 -$9,550,000 0
2020 Q1 2,500,000 $9,550,000 +$611,200 382% 1
2019 Q4 2,340,000 $18,205,000 -$233,397 777.99% 1
2019 Q3 2,370,000 $13,319,000 +$899,173 561.98% 1
2019 Q2 2,210,000 $19,227,000 +$3,555,336 870% 1
2019 Q1 1,800,000 $8,964,000 -$20,940,630 498% 1
2018 Q4 5,471,131 $31,138,734 +$10,760,012 569% 40
2018 Q3 3,748,520 $10,419,780 +$5,382,708 277.98% 26
2018 Q2 1,811,672 $3,986,000 +$975,619 220% 17
2018 Q1 1,372,966 $2,418,000 -$1,587,154 176.08% 15
2017 Q4 2,281,372 $3,878,000 -$536,009 169.99% 19
2017 Q3 2,595,099 $4,176,000 -$3,031,261 160.7% 16
2017 Q2 3,574,586 $11,440,000 +$316,582 320.02% 22
2017 Q1 3,435,269 $14,323,000 +$2,295,385 416.93% 24
2016 Q4 2,944,313 $7,360,000 -$840,654 249.98% 18
2016 Q3 3,267,796 $12,451,000 -$70,090 381.03% 19
2016 Q2 3,286,159 $12,357,000 +$58,225 376.01% 16
2016 Q1 2,645,113 $10,502,000 +$3,735,451 396.98% 19
2015 Q4 2,301,745 $15,950,000 -$269,773 692.38% 19
2015 Q3 1,727,340 $11,093,000 +$673,383 642.31% 18
2015 Q2 1,621,226 $13,179,000 +$3,912,448 812.76% 14
2015 Q1 1,139,854 $9,106,000 +$916,296 799.22% 15
2014 Q4 1,030,530 $7,732,000 +$804,982 750.68% 16
2014 Q3 920,413 $6,831,550 +$3,456,567 742.42% 11
2014 Q2 459,706 $3,192,000 +$72,720 694.26% 11
2014 Q1 450,691 $3,019,000 -$678,133 671.5% 13